Early Findings From Medicare's End-Stage Renal Disease Treatment Choices Model
- PMID: 36206008
- PMCID: PMC10133989
- DOI: 10.1001/jamahealthforum.2022.3500
Early Findings From Medicare's End-Stage Renal Disease Treatment Choices Model
Conflict of interest statement
Dr Tummalapalli received research funding from Scanwell Health and consulting fees from Bayer AG outside the submitted work. Dr Navathe reported grants from the Hawaii Medical Service Association, Commonwealth Fund, Robert Wood Johnson Foundation, Donaghue Foundation, Pennsylvania Department of Health, Veterans Affairs Administration, Ochsner Health System, United Healthcare, Blue Cross Blue Shield of North Carolina, Blue Shield of California, and Humana; personal fees from Navvis Healthcare, YNHHSC/CORE, Maine Health Accountable Care Organization, Singapore Ministry of Health, Elsevier Press, Medicare Payment Advisory Commission, Cleveland Clinic, Analysis Group, VBID Health, Advocate Physician Partners, the Federal Trade Commission, and Catholic Health Services Long Island; equity from Agathos, Inc and Clarify Health; personal fees and equity from Navahealth; and noncompensated board membership for Integrated Services, Inc outside the submitted work in the past 3 years. No other disclosures were reported.
Comment in
-
Medicare Advantage Enrollment Among Beneficiaries With End-Stage Renal Disease in the First Year of the 21st Century Cures Act.JAMA. 2023 Mar 14;329(10):810-818. doi: 10.1001/jama.2023.1426. JAMA. 2023. PMID: 36917063 Free PMC article.
Comment on
-
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical Trial.JAMA Health Forum. 2022 Oct 7;3(10):e223503. doi: 10.1001/jamahealthforum.2022.3503. JAMA Health Forum. 2022. PMID: 36206005 Free PMC article. Clinical Trial.
References
-
- United States Renal Data System. 2021 USRDS annual data report: Accessed September 14, 2022. https://adr.usrds.org/2021
-
- Federal Register. Medicare program: end-stage renal disease prospective payment system, payment for renal dialysis services furnished to individuals with acute kidney injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model. Final Rule. Accessed August 1, 2022. https://www.federalregister.gov/public-inspection/2021-23907/medicare-pr.... - PubMed
-
- Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):191. doi:10.1186/s12955-020-01449-2 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
